Gary S. Gottesman

International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease

Adriana M. Montaño, Shunji Tomatsu, Gary S. Gottesman et al. · Journal of Inherited Metabolic Disease · 2007 · 357 citations

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Erik A. Imel, Francis H. Glorieux, Michael P. Whyte et al. · The Lancet · 2019 · 347 citations · Full text

X-linked Hypophosphataemia, Pediatric Hematology, Hematology +2

Crosslinking of proteins in acetylcholine receptor-rich membranes: Association between the β-subunit and the 43 kd subsynaptic protein

Steven J. Burden, R.L. Depalma, Gary S. Gottesman · Cell · 1983 · 199 citations

Proteinlipid Interaction, Synaptic Plasticity, Signal Transduction +11

Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

Michael P. Whyte, Thomas O. Carpenter, Gary S. Gottesman et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

X-linked Hypophosphataemia, Autoimmune Disease, Pediatric Hematology +5

Marrow Cell Transplantation for Infantile Hypophosphatasia

Michael P. Whyte, Joanne Kurtzberg, William H. McAlister et al. · Journal of Bone and Mineral Research · 2003 · 165 citations · Full text